Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 19, 2022Scientific ReportsOpen Access

In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ANAyele H. NegussieNational Institutes of Health Clinical CenterAMAndrew S. MikhailNational Institutes of HealthJOJoshua OwenUniversity of Science and Technology of China

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Negussie et al. (2022) studied this question.

synapsesocial.com/papers/6a9b7ff7227fa4d2bf7f2666https://doi.org/10.1038/s41598-022-26094-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma2014 · 69 citations
  2. 2Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma2020 · 7,545 citations
  3. 3Development of the Inhibitors That Target the PD-1/PD-L1 Interaction—A Brief Look at Progress on Small Molecules, Peptides and Macrocycles2019 · 156 citations